Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

COVID-19

  • News

    Reassuring data on long-term outcomes among kids with MIS-C

    August 31, 2021

    Most children who develop multisystemic inflammatory syndrome after infection with SARS-CoV-2 recover relatively quickly and without significant sequelae.

  • News

    Long COVID symptoms can persist for more than 1 year, study shows

    August 31, 2021

    The largest study to date confirms that a substantial number of COVID-19 survivors have persistent problems. One researcher calls it a “modern medical challenge of the first order.”

  • News

    CDC panel unanimously backs Pfizer vax, fortifying FDA approval

    August 30, 2021

    The risk of myocarditis after a COVID infection was 6 to 34 times higher than the risk after receiving an mRNA vaccine.

  • News

    Children’s upper airways primed to combat SARS-CoV-2 infection

    August 30, 2021

    The findings may help to explain why children have a lower risk of developing severe COVID-19 illness or becoming infected with SARS-CoV-2 in the first place.

  • News

    U.S. plans COVID-19 booster shots at 6 months instead of 8: WSJ

    August 27, 2021

    Approval of boosters for three COVID-19 shots being administered in the United States is expected in mid-September.

  • 1
    News

    Genetic link may tie cannabis use disorder to severe COVID-19

    August 27, 2021

    “These data have important implications for policy regarding vaccination as well as treatment prioritization,” said lead author Dr. Alexander S. Hatoum.

  • News

    One-third in U.S. had been infected by SARS-CoV-2 through 2020: Study

    August 26, 2021

    “We have not turned the corner on COVID-19 and are nowhere near herd immunity – if it exists for SARS-CoV-2.”

  • 1
    News

    Children and COVID: New cases soar to near-record level

    August 24, 2021

    Vaccine initiations were down for the second consecutive week, but COVID-related deaths showed a big increase.

  • 1
    News

    Health care workers eager for COVID booster shots

    August 23, 2021

    Almost all of the health care workers surveyed – 98% of physicians and 94% of nurses/APNs – have been fully vaccinated against COVID-19.

  • News

    FDA fully approves Pfizer COVID-19 vaccine

    August 23, 2021

    It is the first COVID-19 vaccine to be fully licensed in the United States. It will be marketed under the trade name Comirnaty.

Previous1 … 13 14 15 16 17 … 131Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences